pp65-shLAMP DC with GM-CSF: Clinical Trials

1 trial of pp65-shLAMP DC with GM-CSF, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow pp65-shLAMP DC with GM-CSF: new trials by email Literature Review of pp65-shLAMP DC with GM-CSF trials Research Report on pp65-shLAMP DC with GM-CSF

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
pp65-shLAMP DC with GM-CSF, unpulsed PBMC and saline, Td - Glioblastoma Multiforme, Glioblastoma
Phase 2CompletedUniversity of Florida1752016-08-092025-01-14

Conditions studied

Glioblastoma (1)  ·  Glioma (1)

Sponsors

University of Florida (1)

Countries

United States (1)

Top investigators

Duane Mitchell, MD, PhD (1)  ·  Maryam Rahman, MD (1)

NIH funding

R01CA175517 (1)